Retrospective evaluation of the cases with Candida famata fungemia in a burn unit;Yanιk ünitesinde Candida famata fungemisi gelişen olgularιn retrospektif olarak deǧerlendirilmesi

Mikrobiyoloji Bulteni

Volumn 43, Issue 1, 2009, Pages 71-76

  Turunç, Tuba ^a   Demiroǧlu, Y Ziya ^a   Alişkan, Hikmet ^a   Çolakoǧlu, Şule ^a   Arslan, Hande ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

Burn; Candida famata; Catheter infections; Central venous catheter

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT;

ADULT; ARTICLE; BURN; CANDIDA; CANDIDIASIS; CENTRAL VENOUS CATHETERIZATION; CLASSIFICATION; FEMALE; FUNGEMIA; HUMAN; ISOLATION AND PURIFICATION; MALE; PREVALENCE; RETROSPECTIVE STUDY; TURKEY (REPUBLIC);

AMPHOTERICIN B; ANTIFUNGAL AGENTS; BURN UNITS; BURNS; CANDIDA; CANDIDIASIS; CATHETERIZATION, CENTRAL VENOUS; FEMALE; FUNGEMIA; HUMANS; MALE; PREVALENCE; RETROSPECTIVE STUDIES; TURKEY; YOUNG ADULT;

EID: 59649113547     PISSN: 03749096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Pruitt BA Jr, McManus AT, Kim SH, Goodwin CW. Burn wound infections: current status. World J Surg 1998; 22: 135-45.
2. Becker WK, Cioffi WG Jr, McManus AT, et al. Fungal burn wound infection. A 10-year experience. Arch Surg 1991; 126: 44-8.
3. Gupta A, Mi H, Wroe C, Jaques B, Talbot D. Fatal Candida famata peritonitis complicating sclerosing peritonitis in a peritoneal dialysis patient. Nephrol Dial Transplant 2006; 21: 2036-7.
4. Khan ZU, Misra VC, Randhawa HS, Damodaran VN. Pathogenicity of some ordinarily harmless yeasts for cortisone-treated mice. Sabouraudia 1980; 18: 319-27.
5. Mermel LA, Farr BM, Sherertz RJ, et al. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis 2001; 32: 1249-72.
6. Koneman EW, Allen SD, Janda WM, Schreckenberger PC, Winn WC (eds). Laboratory approach to the diagnosis of fungal infections, p. 1043. Color Atlas and Textbook of Diagnostic Microbiology. 1997, 5th ed. Lippincott-Raven Publishers, New York.
7. BioMerieux API 20 C AUX yeast identification system test instruction.
8. Yemul VL, Sengupta SR. Bacteriology of burns. Burns 1980; 7: 190-3.
9. Signori M, Grappolini S, Magliano E, Donati L. Updated evaluation of the activity of antibiotics in a burn centre. Burns 1992; 18: 500-3.
10. Manson WL, Pernot PC, Fidler V, Sauer EW, Klasen HJ. Colonization of burns and the duration of hospital stay of severely burned patients. J Hosp Infect 1992; 22: 55-63.
11. Donati L, Scammazo F, Gervasoni M, Magliano A, Stankov B, Fraschini F. Infection and antibiotic theraphy in 4000 burned patients treated in Milan, Italy, between 1976 and 1988. Burns 1993; 19: 345-8.
12. Blumberg HM, Jarvis WR, Soucie JM, et al; National Epidemiology of Mycoses Survey (NEMIS) Study Group. Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey. Clin Infect Dis 2001; 33: 177-86.
13. Ellis M, Hedstrom U, Jumaa P, Bener A. Epidemiology, presentation, management and outcome of candidemia in a tertiary care teaching hospital in the United Arab Emirates, 1995-2001. Med Mycol 2003; 41: 521-8.
14. McKinnon PS, Goff DA, Kern JW, et al. Temporal assessment of Candida risk factors in the surgical intensive care unit. Arch Surg 2001; 136: 1401-8.
15. Bukharie HA. Nosocomial candidemia in a tertiary care hospital in Saudi Arabia. Mycopathologia 2002; 153: 195-8.
16. Nucci M, Colombo AC. Risk factors for breakthrough candidemia. Eur J Clin Microbiol Infect Dis 2002; 21: 209-11.
17. Michalopoulos AS, Geroulanos S, Mentzelopoulos SD. Determinants of candidemia and candidemia-related death in cardiothoracic ICU patients. Chest 2003; 124: 2244-55.
18. Wenzel RP. Nosocomial candidemia: risk factors and attributable mortality. Clin Infect Dis 1995; 20: 1531-4.
19. Still JM Jr, Belcher K, Law EJ. Management of candida septicaemia in a regional burn unit. Burns 1995; 21: 594-6.
20. Meyer SA, Ahearn DG, Yarrow D. Candida famata, pp: 675-7. In: Kreger-van Rij WJW (ed), The Yeasts: A Taxonomic Study. 1984, 3rd ed. Elsevier Science Publishers BV, Amsterdam.
21. St-Germain G, Laverdiere M. Torulopsis candida, a new opportunistic pathogen. J Clin Microbiol 1986; 24: 884-5.
22. Eisen LA, Narasimhan M, Berger JS, Mayo PH, Rosen MJ, Schneider RF. Mechanical complications of central venous catheters. J Int Care Med 2006; 21: 40-6.
23. Ramos GE, Bolgiani AN, Patino O, et al. Catheter infection risk related to the distance between insertion site and burned area. J Burn Care Rehabil 2002; 23: 266-71.
24. National Nosocomial Infections Surveillance System (NNIS). NNIS System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004; 32: 470-85.
25. Mermel LA, Farr BM, Sherertz RJ, et al; Infectious Diseases Society of America; American College of Critical Care Medicine; Society for Healthcare Epidemiology of America. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis 2001; 32: 1249-72.
26. Rex JH, Walsh TJ, Sobel JD, et al. Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America. Clin Infect Dis 2000; 30: 662-78.